Israel Englander Poly Pid Ltd. Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.34 - $0.45 $1,727 - $2,286	-5,081 Reduced 19.59%	20,862 $7,000
Q1 2023 May 15, 2023	BUY	$0.4 - $1.08 $10,377 - $28,018	25,943 New	25,943 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $36.9 $67,877 - $2.36 Million	64,035 New	64,035 $74,000
Q3 2021 Nov 15, 2021	SELL	$7.05 - $9.48 $398,536 - $535,904	-56,530 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.4 - $9.99 $287,506 - $341,927	34,227 Added 153.46%	56,530 $512,000
Q1 2021 May 17, 2021	SELL	$8.92 - $15.5 $27,116 - $47,120	-3,040 Reduced 12.0%	22,303 $204,000
Q4 2020 Feb 16, 2021	SELL	$8.89 - $13.5 $511,903 - $777,357	-57,582 Reduced 69.44%	25,343 $252,000
Q3 2020 Nov 16, 2020	SELL	$11.0 - $17.33 $242,671 - $382,317	-22,061 Reduced 21.01%	82,925 $913,000
Q2 2020 Aug 14, 2020	BUY	$18.03 - $19.0 $1.89 Million - $1.99 Million	104,986 New	104,986 $1.89 Million

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $69.6M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.